Kura Oncology, Inc. - Common Stock (KURA)

CUSIP: 50127T109

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class
Equity / Common Stock
Shares outstanding
87,054,674
Total 13F shares
10,310,503
Share change
+471,788
Total reported value
$90,718,000
Price per share
$8.80
Number of holders
34
Value change
+$4,182,413
Number of buys
22
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 50127T109?
CUSIP 50127T109 identifies KURA - Kura Oncology, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of KURA - Kura Oncology, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13F
Company
3.2%
2,815,919
$16,614,000 31 Dec 2016
13F
EcoR1 Capital, LLC
13F
Company
3%
2,611,906
$15,410,000 31 Dec 2016
13F
PFM Health Sciences, LP
13F
Company
2.3%
1,978,429
$11,673,000 31 Dec 2016
13F
CLOUGH CAPITAL PARTNERS L P
13F
Company
0.76%
660,089
$3,895,000 31 Dec 2016
13F
Boxer Capital, LLC
13F
Company
0.61%
533,251
$3,146,000 31 Dec 2016
13F
VANGUARD GROUP INC
13F
Company
0.43%
375,216
$2,214,000 31 Dec 2016
13F
Minerva Advisors LLC
13F
Company
0.37%
322,221
$1,869,000 31 Dec 2016
13F
MORGAN STANLEY
13F
Company
0.18%
156,262
$922,000 31 Dec 2016
13F
ALETHEA CAPITAL MANAGEMENT, LLC
13F
Company
0.07%
64,300
$379,000 31 Dec 2016
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.07%
63,000
$372,000 31 Dec 2016
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.06%
49,256
$290,000 31 Dec 2016
13F
BlackRock Fund Advisors
13F
Company
0.04%
35,904
$212,000 31 Dec 2016
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.04%
30,600
$181,000 31 Dec 2016
13F
PILLAR PACIFIC CAPITAL MANAGEMENT LLC
13F
Company
0.04%
30,500
$180,000 31 Dec 2016
13F
J.P. Morgan Private Wealth Advisors LLC
13F
Company
0.03%
29,500
$174,000 31 Dec 2016
13F
Partner Investment Management, L.P.
13F
Company
0.03%
23,610
$139,000 31 Dec 2016
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.03%
23,500
$139,000 31 Dec 2016
13F
Squarepoint Ops LLC
13F
Company
0.01%
12,518
$74,000 31 Dec 2016
13F
NORTHERN TRUST CORP
13F
Company
0.01%
12,382
$73,000 31 Dec 2016
13F
OPPENHEIMER & CO INC
13F
Company
0.01%
10,900
$64,000 31 Dec 2016
13F
PANAGORA ASSET MANAGEMENT INC
13F
Company
0.01%
9,874
$58,000 31 Dec 2016
13F
DEUTSCHE BANK AG\
13F
Company
0.01%
8,551
$50,000 31 Dec 2016
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
0.01%
7,860
$46,000 31 Dec 2016
13F
CITIGROUP INC
13F
Company
0.01%
5,650
$33,000 31 Dec 2016
13F
BlackRock Investment Management, LLC
13F
Company
0%
2,529
$15,000 31 Dec 2016
13F
UBS Group AG
13F
Company
0%
1,767
$10,000 31 Dec 2016
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0%
904
$5,000 31 Dec 2016
13F
MUFG Americas Holdings Corp
13F
Company
0%
550
$3,000 31 Dec 2016
13F
REILLY FINANCIAL ADVISORS, LLC
13F
Company
0%
200
$1,000 31 Dec 2016
13F

Institutional Holders of Kura Oncology, Inc. - Common Stock (KURA) as of Q1 2017

As of 31 Mar 2017, Kura Oncology, Inc. - Common Stock (KURA) was held by 34 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 10,310,503 shares. The largest 10 holders included FMR LLC, EcoR1 Capital, LLC, Partner Fund Management, L.P., Boxer Capital, LLC, Clough Capital Partners L P, MORGAN STANLEY, VANGUARD GROUP INC, Minerva Advisors LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, and Alethea Capital Management, LLC. This page lists 34 institutional shareholders reporting positions in this security for the Q1 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2017 vs Q4 2016 Across Filers

Q4 2016 holders
29
Q1 2017 holders
34
Holder diff
5
Investor Q4 2016 Shares Q1 2017 Shares Share Diff Share Chg % Q4 2016 Value $ Q1 2017 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .